PRLH

prolactin releasing hormone, the group of Neuropeptides

Basic information

Region (hg38): 2:237566573-237567175

Links

ENSG00000071677NCBI:51052OMIM:602663HGNC:17945Uniprot:P81277AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PRLH gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PRLH gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
10
clinvar
10
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 10 0 0

Variants in PRLH

This is a list of pathogenic ClinVar variants found in the PRLH region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
2-237566629-G-T not specified Uncertain significance (Feb 05, 2024)3218890
2-237566652-C-T not specified Uncertain significance (Dec 27, 2022)2350215
2-237566667-A-T not specified Uncertain significance (Aug 14, 2023)2618293
2-237567026-C-G not specified Uncertain significance (Apr 07, 2022)2281991
2-237567062-G-A not specified Uncertain significance (Sep 20, 2023)3218889
2-237567063-G-C not specified Uncertain significance (Dec 03, 2021)2372921
2-237567095-G-T not specified Uncertain significance (Nov 09, 2021)2376461
2-237567098-G-A not specified Uncertain significance (Feb 06, 2023)2480877
2-237567107-C-G not specified Uncertain significance (Dec 16, 2021)2226372
2-237567111-G-A not specified Uncertain significance (Dec 03, 2021)2263397

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PRLHprotein_codingprotein_codingENST00000165524 2602
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.1080.60900000.00
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.6367762.81.230.00000449530
Missense in Polyphen3621.1021.706169
Synonymous-1.203426.21.300.00000163208
Loss of Function0.26311.330.7545.63e-815

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.000.00
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Stimulates prolactin (PRL) release and regulates the expression of prolactin through its receptor GPR10. May stimulate lactotrophs directly to secrete PRL.;
Pathway
Signaling by GPCR;Signal Transduction;GPCR signaling-G alpha q;GPCR signaling-cholera toxin;GPCR signaling-pertussis toxin;Peptide ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;GPCR signaling-G alpha s Epac and ERK;GPCR signaling-G alpha s PKA and ERK;GPCR signaling-G alpha i (Consensus)

Recessive Scores

pRec
0.138

Intolerance Scores

loftool
0.402
rvis_EVS
-0.3
rvis_percentile_EVS
32.62

Haploinsufficiency Scores

pHI
0.0960
hipred
N
hipred_score
0.123
ghis
0.531

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.231

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Prlh
Phenotype
homeostasis/metabolism phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); liver/biliary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);

Gene ontology

Biological process
tissue homeostasis;reduction of food intake in response to dietary excess;energy reserve metabolic process;lipid metabolic process;G protein-coupled receptor signaling pathway;response to glucose;regulation of signaling receptor activity;response to insulin;regulation of multicellular organism growth;fat cell differentiation;autonomic nervous system development
Cellular component
extracellular region;cytoplasm
Molecular function
hormone activity;neuropeptide hormone activity;prolactin-releasing peptide receptor binding